Alcohol Dependence: Neurobiology, Consequences, and Treatment
Alcohol use disorder (AUD) is a chronic brain disease characterized by impaired control, social impairment, risky use, and pharmacological criteria (tolerance, withdrawal).
Neurobiology
- Reward pathway: Alcohol → ↑ dopamine in nucleus accumbens → reinforcement.
- GABAergic: Potentiates GABA-A → sedation, anxiolysis.
- Glutamatergic: Inhibits NMDA → cognitive impairment; chronic use → upregulation → hyperexcitability on withdrawal.
- Prefrontal cortex: Atrophy → impaired executive function, decision-making, impulse control.
Withdrawal Syndrome
6–24 h post-last drink: anxiety, tremor, tachycardia, nausea. 24–72 h: seizures, hallucinations. 72 h+: delirium tremens (DTs) – mortality 5–15% untreated. Medical detox (benzodiazepines) essential for moderate-severe AUD.
Treatment
- Medications: Naltrexone (craving), acamprosate (abstinence), disulfiram (aversion), topiramate/gabapentin (off-label).
- Psychotherapy: CBT, MET, contingency management, 12-step facilitation.
- Mutual aid: AA, SMART Recovery, LifeRing.
- Levels of care: Outpatient → IOP → residential → medically managed inpatient.
Recovery is non-linear; relapse is common but not failure. Long-term remission achievable.
Drug Addiction - Related Articles
- Alcohol Dependence Screening: A Self-Assessment
- Recognizing Employee Substance Abuse: Signs & Reporting
- Understanding and Overcoming Adderall Addiction: A Comprehensive Guide
- Suboxone Treatment for Opioid Addiction: Cravings & Withdrawal Relief
- Conquer Alcohol Cravings: Strategies for Sobriety
- Understanding Alcohol Abuse & Problem Drinking: Signs & Impact
- Sugar Addiction: Physical, Emotional, and Behavioral Signs
